Comparative  	Comparative  	 JJ	B-NP
characteristics  	characteristics  	 NNS	I-NP
of  	of  	 IN	O
using  	using  	 VBG	O
isoflurane 	isoflurane 	 NN	B-NP
,  	,  	 ,	O
sevoflurane  	sevoflurane  	 NN	B-NP
and  	and  	 CC	O
target  	target  	 NN	B-NP
concentration  	concentration  	 NN	I-NP
of  	of  	 IN	I-NP
propofol  	propofol  	 NN	I-NP
during  	during  	 IN	O
reconstructive  	reconstructive  	 JJ	B-NP
operations  	operations  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
carotid  	carotid  	 JJ	B-NP
arteries  	arteries  	 NNS	I-NP
To  	To  	 TO	O
compare  	compare  	 VB	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
isoflurane 	isoflurane 	 NN	B-NP
,  	,  	 ,	O
sevoflurane  	sevoflurane  	 NN	B-NP
and  	and  	 CC	O
target  	target  	 NN	B-NP
concentration  	concentration  	 NN	I-NP
of  	of  	 IN	I-NP
propofol  	propofol  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
systemic  	systemic  	 JJ	B-NP
hemodynamics 	hemodynamics 	 NN	I-NP
,  	,  	 ,	O
cerebral  	cerebral  	 JJ	B-NP
blood  	blood  	 NN	I-NP
flow  	flow  	 NN	I-NP
and  	and  	 CC	O
cerebral  	cerebral  	 JJ	B-NP
oximetry  	oximetry  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
brain  	brain  	 NN	O
during  	during  	 IN	O
the  	the  	 DT	O
carotid  	carotid  	 JJ	B-NP
endarterectomy 	endarterectomy 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
studied  	studied  	 VBD	O
95  	95  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
3  	3  	 CD	O
groups 	groups 	 NNS	O
.  	.  	 .	O
Group  	Group  	 NN	O
I  	I  	 PRP	O
included  	included  	 VBD	O
26  	26  	 CD	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
received  	received  	 VBD	B-NP
isoflurane  	isoflurane  	 NNS	I-NP
( 	( 	 -LRB-	O
under  	under  	 IN	O
I  	I  	 NNP	O
MAC 	MAC 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
Group  	Group  	 NNP	B-NP
II--40  	II--40  	 NNP	I-NP
patients  	patients  	 NNS	I-NP
who  	who  	 WP	O
received  	received  	 VBD	B-NP
sevoflurane  	sevoflurane  	 NNS	I-NP
( 	( 	 -LRB-	O
under  	under  	 IN	O
I  	I  	 NNP	O
MAC 	MAC 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
Group  	Group  	 NNP	B-NP
III--29  	III--29  	 NNP	I-NP
patients  	patients  	 NNS	I-NP
who  	who  	 WP	O
received  	received  	 VBD	B-NP
target  	target  	 NN	I-NP
concentration  	concentration  	 NN	I-NP
of  	of  	 IN	I-NP
propofol  	propofol  	 NNS	I-NP
( 	( 	 -LRB-	O
under  	under  	 IN	O
4  	4  	 CD	O
mkg 	mkg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
)  	)  	 -RRB-	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
Schneider  	Schneider  	 NNP	O
Studied  	Studied  	 NNP	B-NP
parameters  	parameters  	 NNS	I-NP
were  	were  	 VBD	O
defined  	defined  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
stages 	stages 	 NNS	O
:  	:  	 :	O
before  	before  	 IN	O
the  	the  	 DT	O
operation  	operation  	 NN	O
( 	( 	 -LRB-	O
I 	I 	 PRP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
after  	after  	 IN	O
the  	the  	 DT	O
induction  	induction  	 NN	B-NP
( 	( 	 -LRB-	O
II 	II 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
after  	after  	 IN	O
the  	the  	 DT	O
intubation  	intubation  	 NN	B-NP
( 	( 	 -LRB-	O
III 	III 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
during  	during  	 IN	O
the  	the  	 DT	O
separation  	separation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
carotid  	carotid  	 JJ	B-NP
artery  	artery  	 NN	I-NP
( 	( 	 -LRB-	O
IV 	IV 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
after  	after  	 IN	O
the  	the  	 DT	O
crossclamping  	crossclamping  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
carotid  	carotid  	 JJ	I-NP
artery  	artery  	 NN	I-NP
( 	( 	 -LRB-	O
V 	V 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
before  	before  	 IN	O
starting  	starting  	 VBG	O
the  	the  	 DT	O
bloodstream  	bloodstream  	 NN	O
( 	( 	 -LRB-	O
VI 	VI 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
after  	after  	 IN	O
starting  	starting  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
bloodstream  	bloodstream  	 NN	O
( 	( 	 -LRB-	O
VII 	VII 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
after  	after  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
operation  	operation  	 NN	O
( 	( 	 -LRB-	O
VIII 	VIII 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
At  	At  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
operation 	operation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
using  	using  	 VBG	O
of  	of  	 IN	O
isoflurane 	isoflurane 	 NN	B-NP
,  	,  	 ,	O
sevoflurane  	sevoflurane  	 NN	B-NP
and  	and  	 CC	O
propofol  	propofol  	 NNS	B-NP
was  	was  	 VBD	O
accompanied  	accompanied  	 VBN	O
with  	with  	 IN	O
moderate  	moderate  	 JJ	O
dose-dependent  	dose-dependent  	 JJ	B-NP
lowering  	lowering  	 NN	I-NP
of  	of  	 IN	O
indicators  	indicators  	 NNS	O
ofcirculatory  	ofcirculatory  	 JJ	B-NP
dynamics 	dynamics 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
linear  	linear  	 JJ	B-NP
blood  	blood  	 NN	I-NP
flow  	flow  	 NN	I-NP
velocity  	velocity  	 NN	I-NP
( 	( 	 -LRB-	O
LBFV 	LBFV 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
middle  	middle  	 JJ	O
cerebral  	cerebral  	 JJ	B-NP
artery  	artery  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
affected  	affected  	 JJ	O
side  	side  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
groups  	groups  	 NNS	O
of  	of  	 IN	O
isoflurane  	isoflurane  	 NN	B-NP
and  	and  	 CC	O
propofol  	propofol  	 NNS	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
depend  	depend  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
indicators  	indicators  	 NNS	O
ofcirculatory  	ofcirculatory  	 JJ	B-NP
dynamics 	dynamics 	 NNS	I-NP
;  	;  	 :	O
in  	in  	 IN	O
the  	the  	 DT	O
sevoflurane  	sevoflurane  	 JJ	B-NP
group  	group  	 NN	I-NP
the  	the  	 DT	O
correlation  	correlation  	 NN	O
was  	was  	 VBD	O
traced  	traced  	 VBN	O
During  	During  	 IN	O
the  	the  	 DT	O
breakoff  	breakoff  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
blood  	blood  	 NN	O
circulation  	circulation  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
reconstructed  	reconstructed  	 JJ	O
carotid  	carotid  	 JJ	B-NP
arteries  	arteries  	 NNS	I-NP
while  	while  	 IN	O
using  	using  	 VBG	O
the  	the  	 DT	O
anesthesia  	anesthesia  	 NN	O
of  	of  	 IN	O
isoflurane 	isoflurane 	 NN	B-NP
,  	,  	 ,	O
sevoflurane  	sevoflurane  	 NN	B-NP
and  	and  	 CC	O
propofol  	propofol  	 JJ	B-NP
hemodynamics  	hemodynamics  	 NN	I-NP
was  	was  	 VBD	O
stable 	stable 	 JJ	O
.  	.  	 .	O
LBFV  	LBFV  	 NNP	B-NP
and  	and  	 CC	O
cerebral  	cerebral  	 JJ	B-NP
oximetry  	oximetry  	 NNS	I-NP
( 	( 	 -LRB-	O
CO 	CO 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
groups  	groups  	 NNS	O
of  	of  	 IN	O
isoflurane  	isoflurane  	 NN	B-NP
and  	and  	 CC	O
propofol  	propofol  	 NNS	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
depend  	depend  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
systemic  	systemic  	 JJ	B-NP
hemodynamics 	hemodynamics 	 NN	I-NP
;  	;  	 :	O
in  	in  	 IN	O
the  	the  	 DT	O
sevoflurane  	sevoflurane  	 JJ	B-NP
group--they  	group--they  	 JJ	I-NP
depended  	depended  	 NN	I-NP
After  	After  	 IN	O
the  	the  	 DT	O
reinitiating  	reinitiating  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
bloodstream  	bloodstream  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
conditions  	conditions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
isoflurane  	isoflurane  	 JJ	B-NP
andpropofol  	andpropofol  	 NNS	I-NP
anesthesia  	anesthesia  	 VBP	I-NP
the  	the  	 DT	O
reperfusion  	reperfusion  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
brain  	brain  	 NN	O
was  	was  	 VBD	O
moderate 	moderate 	 JJ	O
;  	;  	 :	O
in  	in  	 IN	O
the  	the  	 DT	O
conditions  	conditions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
sevoflurane  	sevoflurane  	 NN	B-NP
anesthesia  	anesthesia  	 VBD	I-NP
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
reperfusion  	reperfusion  	 JJ	B-NP
damage  	damage  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
brain  	brain  	 NN	O
during  	during  	 IN	O
the  	the  	 DT	O
uncontrolled  	uncontrolled  	 JJ	O
hypertension  	hypertension  	 NN	O
remained 	remained 	 VBD	O
.  	.  	 .	O
At  	At  	 IN	O
the  	the  	 DT	O
stage  	stage  	 NN	O
of  	of  	 IN	O
finishing  	finishing  	 VBG	O
the  	the  	 DT	O
operation  	operation  	 NN	B-NP
LBFV  	LBFV  	 NNP	I-NP
and  	and  	 CC	O
CO  	CO  	 NNP	O
did  	did  	 VBD	O
not  	not  	 RB	O
depend  	depend  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
systemic  	systemic  	 JJ	B-NP
hemodynamics  	hemodynamics  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
isoflurane  	isoflurane  	 NN	B-NP
and  	and  	 CC	O
propofol  	propofol  	 JJ	B-NP
groups 	groups 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
sevoflurane  	sevoflurane  	 JJ	B-NP
group  	group  	 NN	I-NP
the  	the  	 DT	O
dependence  	dependence  	 NN	O
was  	was  	 VBD	O
indicated 	indicated 	 VBN	O
.  	.  	 .	O
Consequently 	Consequently 	 RB	O
,  	,  	 ,	O
at  	at  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
operation  	operation  	 NN	O
we  	we  	 PRP	O
indicated  	indicated  	 VBD	O
the  	the  	 DT	O
disorder  	disorder  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
brain  	brain  	 NN	B-NP
blood  	blood  	 NN	I-NP
supply  	supply  	 NN	I-NP
autoregulation  	autoregulation  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
sevoflurane  	sevoflurane  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
